neuregulin (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
neuregulin
Neuregulin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+neuregulin+1+beta+1/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/bio_rxiv__64898__2026__03__17__709302-71-13-15
Average 95 stars, based on 124 article reviews
Neuregulin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+recombinant+neuregulin+1+beta+1/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/bio_rxiv__64898__2026__03__17__709302-71-13-15
Average 95 stars, based on 124 article reviews
neuregulin - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Purification:Article Title: Tight Spaces, Tighter Signals: Spatial Constraints as Drivers of Peripheral Myelination Article Snippet: Fibroblasts were eliminated by treatment with 10 μM cytosine β- D -arabinofuranoside (ARA-C; Sigma-Aldrich, St. Louis, MO, USA) and subsequent incubation with an anti-Thy 1.1 monoclonal antibody (R&D Systems, Minneapolis, MN, USA) followed by rabbit complement (VWR, Radnor, PA, USA). .. Purified SCs were expanded in DMEM supplemented with 10% FCS, 1% P/S, 4 mM forskolin (Sigma-Aldrich, St. Louis, MO, USA), and 10 ng/mL Article Title: Tight Spaces, Tighter Signals: Spatial Constraints as Drivers of Peripheral Myelination. Article Snippet: Fibroblasts were eliminated by treatment with 10 μM cytosine β-D-arabinofuranoside (ARA-C; Sigma-Aldrich, St. Louis, MO, USA) and subsequent incubation with an anti-Thy 1.1 monoclonal antibody (R&D Systems, Minneapolis, MN, USA) followed by rabbit complement (VWR, Radnor, PA, USA). .. Purified SCs were expanded in DMEM supplemented with 10% FCS, 1% P/S, 4 mM forskolin (Sigma-Aldrich, St. Louis, MO, USA), and 10 ng/mL Recombinant:Article Title: Tight Spaces, Tighter Signals: Spatial Constraints as Drivers of Peripheral Myelination Article Snippet: Fibroblasts were eliminated by treatment with 10 μM cytosine β- D -arabinofuranoside (ARA-C; Sigma-Aldrich, St. Louis, MO, USA) and subsequent incubation with an anti-Thy 1.1 monoclonal antibody (R&D Systems, Minneapolis, MN, USA) followed by rabbit complement (VWR, Radnor, PA, USA). .. Purified SCs were expanded in DMEM supplemented with 10% FCS, 1% P/S, 4 mM forskolin (Sigma-Aldrich, St. Louis, MO, USA), and 10 ng/mL Article Title: Tight Spaces, Tighter Signals: Spatial Constraints as Drivers of Peripheral Myelination. Article Snippet: Fibroblasts were eliminated by treatment with 10 μM cytosine β-D-arabinofuranoside (ARA-C; Sigma-Aldrich, St. Louis, MO, USA) and subsequent incubation with an anti-Thy 1.1 monoclonal antibody (R&D Systems, Minneapolis, MN, USA) followed by rabbit complement (VWR, Radnor, PA, USA). .. Purified SCs were expanded in DMEM supplemented with 10% FCS, 1% P/S, 4 mM forskolin (Sigma-Aldrich, St. Louis, MO, USA), and 10 ng/mL |